ALDX FY 2017 Earnings — Aldeyra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ALDXAldeyra Therapeutics, Inc.

$290M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$37,849

Operating Income

-$22M

Net Income

-$22M

EPS (Diluted)

$-1.40

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$44M

Total Liabilities

$5M

Stockholders' Equity

$40M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$37,849	-$35,792	-5.7%
Operating Income	-$22M	-$19M	-20.3%
Net Income	-$22M	-$19M	-19.5%